Phibro Animal Health Corporation (PAHC) Financials

PAHC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.5 billion 1.1 billion
March 31, 2026 1.4 billion 1.1 billion
Dec. 31, 2025 1.4 billion 1.1 billion
Sept. 30, 2025 1.4 billion 1.1 billion

PAHC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 5.2 million ?
March 31, 2026 890000 411000
Dec. 31, 2025 8.3 million 434000
Sept. 30, 2025 -4.5 million 339000

PAHC Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 21.7 million
March 31, 2026 24.0 million
Dec. 31, 2025 27.5 million
Sept. 30, 2025 26.5 million

PAHC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 82.0 million 707.8 million 56.0 million
March 31, 2026 77.5 million 712.7 million 51.9 million
Dec. 31, 2025 74.5 million 710.6 million 41.9 million
Sept. 30, 2025 85.3 million 724.5 million 42.1 million

PAHC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 41.0 million
March 31, 2026 41.0 million
Dec. 31, 2025 41.0 million
Sept. 30, 2025 40.9 million

PAHC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 18.9 million - 86.2 million -
March 31, 2026 15.3 million - 76.9 million -
Dec. 31, 2025 11.1 million - 77.9 million -
Sept. 30, 2025 13.8 million - 71.5 million -

PAHC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 396.7 million 262.3 million
March 31, 2026 383.5 million 257.9 million
Dec. 31, 2025 373.9 million 241.3 million
Sept. 30, 2025 363.9 million 244.1 million

PAHC Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PAHC

Price: $37.98

52 week price:
28.25
60.08

Dividend Yield: 1.29%

5-year range yield:
0.82%
4.92%

Forward Dividend Yield: 1.27%

Payout Ratio: 800.00%

Payout Ratio Range:
-60.64%
800.00%

Dividend Per Share: 0.48 USD

Earnings Per Share: 2.47 USD

P/E Ratio: 15.53

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 51500

Ebitda: 30.9 million

Market Capitalization: 1.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 13

DGR10: 2.00%

Links: